Research and Markets: Building the Case for Biotechnology Features Management Case Studies in Science, Laws, Regulations, Politics, and Business

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bd9d14/building_the_case) has announced the addition of the "Building the Case for Biotechnology" book to their offering.

Case studies capture the complexity and context of the biotech industry, and effectively create a bridge between studying books and working in a business. This book was created to fill the gap in biotechnology entrepreneurship and management education. The case method of teaching is a proven and engaging pedagogical approach that is part and parcel of medical, business and legal education. By simulating and analyzing problems, students have the opportunity to practice decision making in uncertainty with little business risk (although possibly substantial academic risk), create alternative solutions, and gain the benefit of seeing how their recommendations compare to the actual outcomes.

We all, particularly scientific entrepreneurs and managers, learn more from doing. Simulating successes and failures, as well as how to cope and learn from those experiences, is a critical survival skill that can be honed by case study analysis. This volume helps to fill the void in life science entrepreneurship and management case books and provides faculty and students with not only the charts, but the simulated experience of sailing the turbulent and exciting oceans of the biomedical industry toward creating significant value for patients and society.

Building the Case for Biotechnology features:

Foreword by G. Steven Burrill
An introductory chapter on how to teach bioscience using the case method
22 case studies in science; laws, regulations, politics; and business
Ample figures, graphs, and tables to complement the text
Resources for further reading

Key Topics Covered:

G. Steven Burrill Burrill & Company
Mark J. Ahn, Michael A. Alvarez, Arlen D. Meyers, Anne S. York
How to Teach Bioscience Using the Case Discussion Method Trent Wachner and Anne S. York College of Business, Creighton University Part I: Science
Medarex: Realizing its Potential? Mark J. Ahn, Alan Leong, Wei Wu, and Masum Rahman Atkinson Graduate School of Management, Willamette University; University of Washington, Bothell
FoxHollow Technologies: The SilverHawk Cuts Open a New Market Erik Miller, Dina Finan, and Michael Alvarez Stanford University
OraPharma: Reformulation of an Existing Product Payam Benyamini, Mark J. Ahn, and Danielle Hathaway University of California, Los Angeles; Atkinson Graduate School of Management, Willamette University
DesignMedix: Maintain Product Focus or Leverage Technology Platform?
Elizabeth R. Bivins-Smith, Bettina M. Frana, and W. Kellogg Thorsel School of Business Administration, Portland State University
Oxigene: Realizing Value from Multiple Technology Platforms Mark J. Ahn, Anne S. York, David Ackerley and Rebecca Bednarek Atkinson Graduate School of Management, Willamette University; College of Business, Creighton University; and Victoria University of Wellington
Part II: Laws, Regulations, Politics
Tysabri Re-launch Decision: Promise and Perils of Addressing Unmet Needs Mark J. Ahn & Laura Ueki Atkinson Graduate School of Management, Willamette University
XDx: Navigating Regulatory & Reimbursement Challenges Laura Elias and Michael Alvarez Stanford University Dyadic International: From Doom to Dawn What's Next?
Polly S. Rizova, Adelaida Patrasc Lungu, and Mark J. Ahn
Atkinson Graduate School of Management, Willamette University
The Prince Edward Island Bioscience Cluster: Creating a Knowledge-Based Economy Steven Casper, Juergen Krause, and Adelee MacNevin
Keck Graduate Institute of Applied Life Sciences and University of Prince Edward Island
The Founding and Growth of On-Q-ity: Developing Advances in Personalized Medicine Daniel Dornbusch and Mark J. Ahn
Novartis International AG; Atkinson Graduate School of Management, Willamette University
Airway Tools Company: Changing Medical Device Standards of Care Andrew Maxwell, Bahram Behnam Azad, Michael Alvarez University of Toronto; Stanford University
Part III: Business
Genentech Acquisition by Roche: Will Innovation Wither? Mark J. Ahn, Anne S. York, David Ackerley, Hannah A. Pearce, Mark J. Calcott, Natelle C. Quek, Sonai Lim, Rochene E. Higginson, Hannah D. Hoang, and David Lee Atkinson Graduate School of Management, Willamette University; College of Business, Creighton University; and School of Biological Sciences, Victoria University of Wellington
Myogen: Are We There Yet? Mark J. Ahn and Travis Cook Atkinson Graduate School of Management, Willamette University
Compression Dynamics: In Search of Sales Anne S. York and Martin Winkler College of Business, Creighton University and University of Nebraska Medical Center, Creighton University Medical Center
iKaryos Diagnostics: The Rocky Road from Concept to Startup Anne S. York College of Business, Creighton University Biocon: From Local to Global Ashish Hajela, Shad Shahid, & Mohammad Akbar Indian Institute of Management, Lucknow, India
Adnexus: Strategic and Resource Considerations When Developing Novel Biotechnology Medicines Susan Sieloff, Tucker Marion, John Friar, and Raymond Kinnunen College of Business Administration, Northeastern University
Gardasil: From University Discovery to Global Blockbuster Drug Alan Collier, Mark J. Ahn and Brendan Gray University of Otago; Atkinson Graduate School of Management, Willamette University Guru Instruments: Bootstrapping a Bioscience Device Startup Anne S. York College of Business, Creighton University
Growing Pains at Camelot Biopharmaceuticals Lynn Johnson Langer
Johns Hopkins University
Sandhill Scientific: Where to Manufacture? Staci D. Sanford and Arlen Meyers University of Colorado Denver
Lumina Life Sciences: The Challenges of Raising Capital to take to Market a Promising Technology Innovation Magda Choruzy, Andrew Maxwell, Michael Alvarez